Search - tctmd.com

Displaying 1 - 20 of 214

Sort: Relevancy | Date

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Conference News AHA 2016

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Michael O'Riordan

November 15, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Anthony H. Gershlick

October 30, 2016

Presentation TCT 2016

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

Presenter: Jung-Min Ahn

October 30, 2016

Presentation TCT 2016

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Daily News

Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms

Todd Neale

October 28, 2016

News Daily News

STEMI 患者 CTO PCI 前沿：EXPLORE 带来更多问题

Yael L. Maxwell

October 05, 2016

News Daily News

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Yael L. Maxwell

October 05, 2016

News Daily News

En la Frontera de las PCI para el Manejo de OTC para Pacientes STEMI: Las Respuestas Llevan a Más Preguntas en el EXPLORE

Yael L. Maxwell

October 05, 2016

Advertisement

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms

STEMI 患者 CTO PCI 前沿：EXPLORE 带来更多问题

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

En la Frontera de las PCI para el Manejo de OTC para Pacientes STEMI: Las Respuestas Llevan a Más Preguntas en el EXPLORE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content